SCHEDULE 13G: Wasatch Advisors Discloses 5.6% Passive Stake in MacroGenics Inc.

Wasatch Advisors LP has reported a passive 5.6% ownership stake in biopharmaceutical company MacroGenics Inc., holding 3,488,493 shares of common stock as of December 31, 2024.

Summary

• Wasatch Advisors LP, an investment adviser, has filed a Schedule 13G indicating beneficial ownership of 3,488,493 shares of MacroGenics Inc. common stock.
• This stake represents 5.6% of MacroGenics Inc.'s outstanding common stock.
• Wasatch Advisors LP holds sole voting power and sole dispositive power over all 3,488,493 shares.
• The filing confirms that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The filing itself is neutral as a regulatory disclosure. However, the disclosure of a significant passive stake by a reputable investment adviser like Wasatch Advisors LP can be perceived as a slightly positive signal, indicating institutional confidence or interest in MacroGenics Inc.

Positives

• Increased institutional ownership by Wasatch Advisors LP, a reputable investment adviser, which can be seen as a vote of confidence in MacroGenics Inc.
• The passive nature of the investment (Schedule 13G filing) suggests that Wasatch Advisors LP is not seeking to influence or control the company's management or strategic direction.

Future Outlook

The document does not provide any forward-looking statements or guidance from MacroGenics Inc. or Wasatch Advisors LP regarding MacroGenics Inc.'s future performance or strategic direction.

Management Comments

• The document does not contain any notable quotes or paraphrased statements from MacroGenics Inc. management. The filing is signed by Mike Yeates, CEO of Wasatch Advisors LP, certifying the accuracy of the ownership information.

Industry Context

This filing indicates growing or continued institutional interest in the biopharmaceutical sector, specifically in companies like MacroGenics Inc. The acquisition of a significant passive stake by an investment adviser like Wasatch Advisors LP is a common occurrence in the investment landscape, reflecting portfolio allocation decisions within the broader market.

Comparison to Industry Standards

• This document, a Schedule 13G filing, is a standard regulatory disclosure for passive ownership stakes exceeding 5%.
• It does not contain information that allows for a direct comparison of MacroGenics Inc.'s operational or financial results against industry benchmarks or specific comparable companies/projects.
• The filing solely details an investment firm's stake.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor's stake may positively influence market perception and potentially attract further institutional interest, which could impact share liquidity and valuation.
• Management: The passive nature of the stake indicates no immediate intent by Wasatch Advisors LP to influence management or corporate strategy, allowing current management to continue their planned operations.

Key Dates

Keywords

MacroGenics Inc, Wasatch Advisors LP, Schedule 13G, Common Stock, Institutional Ownership, Biopharmaceutical, Investment Adviser, Passive Investment, SEC Filing